Nisa Investment Advisors LLC decreased its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 17.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,880 shares of the technology company's stock after selling 4,305 shares during the period. Nisa Investment Advisors LLC's holdings in Amdocs were worth $1,829,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the business. Axxcess Wealth Management LLC lifted its holdings in Amdocs by 5.4% during the 4th quarter. Axxcess Wealth Management LLC now owns 2,431 shares of the technology company's stock valued at $207,000 after buying an additional 124 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Amdocs by 17.5% during the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock worth $90,000 after acquiring an additional 147 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Amdocs by 55.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after acquiring an additional 208 shares in the last quarter. Fifth Third Bancorp increased its stake in Amdocs by 3.1% during the 1st quarter. Fifth Third Bancorp now owns 7,537 shares of the technology company's stock valued at $690,000 after purchasing an additional 225 shares in the last quarter. Finally, Donald L. Hagan LLC increased its stake in Amdocs by 1.3% during the 1st quarter. Donald L. Hagan LLC now owns 17,456 shares of the technology company's stock valued at $1,597,000 after purchasing an additional 226 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Amdocs Stock Performance
NASDAQ DOX traded up $1.26 during mid-day trading on Wednesday, reaching $89.31. 323,294 shares of the stock were exchanged, compared to its average volume of 664,987. The business's 50 day moving average is $91.56 and its 200-day moving average is $88.36. Amdocs Limited has a 1 year low of $78.61 and a 1 year high of $95.41. The company has a market capitalization of $10.08 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.47 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.16 and a current ratio of 1.16.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.07. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The company's revenue was down 9.4% compared to the same quarter last year. During the same period last year, the firm posted $1.56 earnings per share. On average, equities research analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Monday, June 30th will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a yield of 2.36%. The ex-dividend date of this dividend is Monday, June 30th. Amdocs's dividend payout ratio (DPR) is presently 44.42%.
Analyst Ratings Changes
A number of research analysts have issued reports on DOX shares. Wolfe Research began coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, June 7th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $105.33.
Read Our Latest Stock Analysis on Amdocs
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
